Search Results - "Hjortland, G"

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial by Nilsson, K., Klevebro, F., Sunde, B., Rouvelas, I., Lindblad, M., Szabo, E., Halldestam, I., Smedh, U., Wallner, B., Johansson, J., Johnsen, G., Aahlin, E.K., Johannessen, H.-O., Alexandersson von Döbeln, G., Hjortland, G.O., Wang, N., Shang, Y., Borg, D., Quaas, A., Bartella, I., Bruns, C., Schröder, W., Nilsson, M.

“…The optimal time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer is unknown and has traditionally been 4-6 weeks in clinical…”
Get full text

NETest in advanced high‐grade gastroenteropancreatic neuroendocrine neoplasms by Sorbye, H., Hjortland, G. O., Vestermark, L. W., Sundlov, A., Assmus, J., Couvelard, A., Perren, A., Langer, S. W.

“…Molecular blood biomarkers are lacking for high‐grade (HG) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN). To histologically distinguish between…”
Get full text

Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas by Galleberg, R.B, Knigge, U, Tiensuu Janson, E, Vestermark, L.W, Haugvik, S.-P, Ladekarl, M, Langer, S.W, Grønbæk, H, Österlund, P, Hjortland, G.O, Assmus, J, Tang, L, Perren, A, Sorbye, H

“…Abstract Background Gastroenteropancreatic neuroendocrine carcinomas (GEP-NEC) are generally characterized by synchronous metastases, high aggressiveness and a…”
Get full text

North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis by Claassen, Y.H.M., Dikken, J.L., Hartgrink, H.H., de Steur, W.O., Slingerland, M., Verhoeven, R.H.A., van Eycken, E., de Schutter, H., Johansson, J., Rouvelas, I., Johnson, E., Hjortland, G.O., Jensen, L.S., Larsson, H.J., Allum, W.H., Portielje, J.E.A., Bastiaannet, E., van de Velde, C.J.H.

“…As older gastric cancer patients are often excluded from randomized clinical trials, the most appropriate treatment strategy for these patients remains…”
Get full text

Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum by Uzdensky, A.B., Juzeniene, A., Kolpakova, E., Hjortland, G.-O., Juzenas, P., Moan, J.

“…Effects of photodynamic therapy (PDT) on adhesion of human adenocarcinoma cells of the line WiDr to a plastic substratum were investigated. Protoporphyrin IX…”
Get full text

International comparison of treatment strategy and survival in metastatic gastric cancer by Claassen, Y H M, Bastiaannet, E, Hartgrink, H H, Dikken, J L, de Steur, W O, Slingerland, M, Verhoeven, R H A, van Eycken, E, de Schutter, H, Lindblad, M, Hedberg, J, Johnson, E, Hjortland, G O, Jensen, L S, Larsson, H J, Koessler, T, Chevallay, M, Allum, W H, van de Velde, C J H

“…In the randomized Asian REGATTA trial, no survival benefit was shown for additional gastrectomy over chemotherapy alone in patients with advanced gastric…”
Get full text

Growth of precultured human glioma specimens in nude rat brain by ENGEBRAATEN, O, HJORTLAND, G. O, HIRSCHBERG, H, FODSTAD, Ø

“…The aim of this study was to develop an improved animal model for brain tumor study. The need for better and more relevant brain tumor models is generally…”
Get full text

Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines by Uzdensky, A B, Ma, L W, Iani, V, Hjortland, G O, Steen, H B, Moan, J

“…Hypericin, a natural polycyclic quinone extracted from Hypericum perforatum, has been recently shown to be a powerful sensitiser for photodynamic therapy…”
Get full text

P-93 Safety and feasibility of irradiation and nivolumab in esophageal cancer – a phase I/II study by Hjortland, G., Aasand, K., Kumar, T., Hernes, E., Knutsen, B., Nilssen, Y., Kyte, J., Guren, T., Hauge, T., Johannessen, H.

Get full text

Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1 by Hjortland, G O, Bjørnland, K, Pettersen, S, Garman-Vik, S S, Emilsen, E, Nesland, J M, Fodstad, O, Engebraaten, O

“…A number of studies have emphasized the role of PAI-1 as an important regulator of tumor cell invasion and metastasis. The hallmark of primary tumors of the…”
Get full text

O148 SHORT-TERM RESULTS OF A RANDOMIZED CONTROLLED TRIAL OF STANDARD VS. PROLONGED TIME TO SURGERY AFTER NEOADJUVANT CHEMORADIATION FOR CANCER by Nilsson, K, Klevebro, F, Szabo, E, Halldestam, I, Johnsson, E, Wallner, B, Johansson, J, Johnsen, G, Aahlin, E K, Hjortland, G O, Bruns, C, Schröder, W, Nilsson, M

Get full text

525 SURGICAL MORBIDITY AND MORTALITY FROM THE NEORESII TRIAL: STANDARD VS. PROLONGED TIME TO SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER by Nilsson, K, Klevebro, F, Rouvelas, I, Lindblad, M, Szabo, E, Halldestam, I, Smedh, U, Wallner, B, Johansson, J, Johnsen, G, Kjus Ahlin, E, Johannessen, H, Hjortland, G, Bartella, I, Schröder, W, Bruns, C, Nilsson, M

Get full text

Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer by Nilsson, Klara, Klevebro, Fredrik, Rouvelas, Ioannis, Lindblad, Mats, Szabo, Eva, Halldestam, Ingvar, Smedh, Ulrika, Wallner, Bengt, Johansson, Jan, Johnsen, Gjermund, Aahlin, Eirik Kjus, Johannessen, Hans-Olaf, Hjortland, Geir Olav, Bartella, Isabel, Schröder, Wolfgang, Bruns, Christiane, Nilsson, Magnus

“…OBJECTIVE:To investigate if prolonged TTS after completed nCRT improves postoperative outcomes for esophageal and esophagogastric junction cancer. SUMMARY OF…”
Get full text

5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review) by Friesen, Scott A, Hjortland, Geir Olav, Madsen, Steen J, Hirschberg, Henry, Engebraten, Olav, Nesland, Jahn M, Peng, Qian

“…With current treatment methods the prognosis for patients with aggressive brain tumors is dismal. Treatment failure is usually due to local recurrence of…”
Get more information

Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals by Engebraaten, Olav, Hjortland, Geir Olav, Juell, Siri, Hirschberg, Henry, Fodstad, Øystein

“…Treatment of malignant brain tumors remains a clinical challenge. New treatment modalities are under investigation and among these are intratumoral infusion of…”
Get full text

Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme by GEIR OLAV HJORTLAND, GARMAN-VIK, Solveig Suzanne, JUELL, Siri, ØYVIND EDON OLSEN, HIRSCHBERG, Henry, FODSTAD, Øystein, ENGEBRAATEN, Olav

“…The aim of this study was to target immunotoxin treatment to the high-molecular-weight melanoma-associated antigen (HMW-MAA) and thereby examine any changes in…”
Get full text

Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells by Hjortland, Geir Olav, Lillehammer, Trine, Somme, Stig, Wang, Junbai, Halvorsen, Thomas, Juell, Siri, Hirschberg, Henry, Fodstad, Øystein, Engebraaten, Olav

“…The level of plasminogen activator inhibitor-1 (PAI-1) in tumor tissue has been shown to be an independent negative prognostic factor in different cancers…”
Get full text

Establishment and characterization of two breast cancer xenografts in immunodeficient mice for studies on hormone-dependent and hormone-independent tumor growth, progression and invasion by Engebraaten, O, Hjortland, GO, Martinsen, M, Halvorsen, T, Fodstad, Ø, Ree, AH

Get full text